New Tools to Define Intervention in Asymptomatic Carotid Disease

This meta-analysis included 14 studies and compared the uptake of fluorodeoxyglucose (18F-FDG) according to positron emission tomography (PET)/computed tomography (CT) in symptomatic versus asymptomatic patients, demonstrating a significantly higher uptake in patients with symptomatic lesions. While PET/CT imaging of atheroma is a tool under investigation, with limited applicability in clinical practice, in a relatively close future, it might give insight into plaque biology so as to identify cases most likely to result in stroke. If so, it would become another tool to define intervention in patients who are asymptomatic but present highly inflamed and eventually unstable plaque.

This work included 539 symptomatic and asymptomatic patients who were assessed through PET/CT. Results were clear: patients with symptomatic lesions demonstrated a significantly higher tracer uptake (mean difference: 0.94; p < 0.0001).

 

Approximately 80% of strokes are ischemic in nature, and carotid lesions are deemed the source in 10% of cases. There is strong evidence that early intervention is key in reducing stroke rates in patients with significant symptomatic ipsilateral carotid disease. However, in asymptomatic patients, there are very few tools supporting intervention and most are in clear support of conservative management by best medical therapy available. Only a small proportion of asymptomatic patients with significant carotid artery lesions will develop a stroke or transient ischemic attack; having tools that will help to identify these patients might lead to interventions that will reduce the risk of future events. The use of 18F-FDG in PET/CT might be this new tool.

 

Conclusion

The use of 18F-FDG in PET/CT can demonstrate carotid plaque inflammation as a marker of symptomatic disease. Further studies are required to add these imaging techniques to clinical practice.

 

Original title: 18F-FDG Uptake on PET/CT in Symptomatic Versus Asymptomatic Carotid Disease: A Meta-Analysis.

Reference: Mohammed M. Chowdhury et al. Eur J Vasc Endovasc Surg (2018). Article in press.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....

Chronic Thromboembolic Pulmonary Hypertension: Treatment Outcomes According to a Worldwide Registry

Chronic thromboembolic pulmonary hypertension (CTEPH) is a highly limiting condition that, despite its moderate incidence, significantly impacts patient prognosis and quality of life. The...

Contemporary Outcomes of Acute Limb Ischemia Endovascular Revascularization

Acute limb ischemia (ALI) is a vascular emergency with high mortality rate. It has been defined as a sudden occlusion of limb perfusion compromising...

TCT 2024 | SIRONA: Randomized Study Comparing Sirolimus-Coated vs Paclitaxel-Coated Balloon Angioplasty in Femoropopliteal Disease

This prospective, randomized, multicenter, investigator-initiated non-inferiority study compared the use of sirolimus-coated balloon (MagicTouch) vs paclitaxel-coated balloon in endovascular treatment.  The primary objective was to...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

1-Year Outcomes of US TAVR Registry with 5th Generation Balloon Expandable Valves

The use of transcatheter aortic valve replacement (TAVR) has extended to younger patients with lower risk severe aortic stenosis (AS) and therefore the improvement...

EuroSMR Registry: Edge-to-Edge Mitral Treatment with 5-Year Outcomes

Cardiomyopathies and left atrial enlargement can lead to secondary mitral regurgitation (SMR). This condition is associated with ventricular dysfunction, causing heart failure, hospitalization, and...

TricValve Transcatheter Bicaval Valve System for Severe Tricuspid Insufficiency: Events at One Year

TricValve is the first bicaval valve system to obtain CE-Mark approval. This device heterotopic device eliminates tricuspid insufficiency reflux into the venous system, reducing...